Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals
Open Access
- 1 February 2017
- journal article
- research article
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (2) , 130-135
Abstract
No abstract availableKeywords
Funding Information
- Health Innovation Challenge Fund (HICF-1009-003)
- Wellcome Trust and the Department of Health, and the Wellcome Trust Sanger Institute (WT098051)
- Cambridge South REC (10/H0305/83)
- Republic of Ireland REC (GEN/284/12)
This publication has 9 references indexed in Scilit:
- Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defectsHuman Molecular Genetics, 2016
- A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case reportBMC Neurology, 2016
- Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research dataThe Lancet, 2015
- De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrumHuman Genetics, 2014
- A new intellectual disability syndrome caused by CTNNB1 haploinsufficiencyAmerican Journal of Medical Genetics Part A, 2014
- Dominant β-catenin mutations cause intellectual disability with recognizable syndromic featuresJournal of Clinical Investigation, 2014
- Diagnostic Exome Sequencing in Persons with Severe Intellectual DisabilityNew England Journal of Medicine, 2012
- β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the SkinCell, 2001
- Inactivation of the β-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial developmentDevelopment, 2001